AT 56Compound sixty has a very significant affinity to MDM2 (Ki ... It can be therefore required to produce innovative ways for more efficient concentrating on of MDM2. These ways need to goal to enhance therapeutic results by addressing challenges relevant to transient p53 accumulation and likely adverse effects in regular tissues (Li et al.Move t